Trials / Completed
CompletedNCT03009916
Bileacid Malabsorption and GLP-1 Secretion
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to examine the influence of BAM on postprandial GLP--1 secretion and glucose homeostasis, both with and without bile acid sequestration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | "cholestagel®" (Colesevelam) | 3750mg |
| DRUG | Placebos | 3750mg |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-08-03
- Completion
- 2017-08-04
- First posted
- 2017-01-04
- Last updated
- 2017-08-07
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03009916. Inclusion in this directory is not an endorsement.